Psycheceutical
Fort Lauderdale, US · Founded 2020 · Florida corporation
PsycheCeutical is a pharmaceutical company developing drug treatments related to brain injury, mental health, and neurological conditions such as traumatic brain injury, PTSD, and post-concussion syndrome. Its team combines neurosurgeons, neurologists, and pharmaceutical development specialists focused on therapeutics linking mental and physical health.
Founders & leadership
CH
Chad HarmanNamed on SEC filing
NK
Neilank K. Jha
MH
Michael Hlavsa
Reported raises · per SEC filings
Form D private placements$405K disclosed across 1 round · 2021
▶$405KraisedOct 2021 · 8 investors · PharmaceuticalsRule 506(b)
▶$405KraisedOct 2021 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chad HarmanExecutive Officer
- Offering amount
- $2M
- Amount sold
- $405K
- Minimum investment
- $25K
- First sale
- Sep 2021
- Incorporated
- Corporation, Florida, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Psycheceutical do?
- PsycheCeutical is a pharmaceutical company developing drug treatments related to brain injury, mental health, and neurological conditions such as traumatic brain injury, PTSD, and post-concussion syndrome. Its team combines neurosurgeons, neurologists, and pharmaceutical development specialists focused on therapeutics linking mental and physical health.
- How much funding has Psycheceutical raised?
- Psycheceutical has disclosed $405K raised across 1 round.
- Where is Psycheceutical headquartered?
- Psycheceutical is headquartered in Fort Lauderdale, US.